[1] Brouns SJ, Jore MM, Lundgren M, et al.Small CRISPR RNAs guide antiviral defense in prokaryotes[J]. Science, 2008, 321(5891):960-964. [2] Sapranauskas R, Gasiunas G, Fremaux C, et al.The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli[J]. Nucleic Acids Research, 2011, 39(21):9275-9282. [3] Wiedenheft B, Sternberg SH, Doudna JA.RNA-guided genetic silencing systems in bacteria and archaea[J]. Nature, 2012, 482(7385):331-338. [4] Burgess DJ.Technology:a CRISPR genome-editing tool[J]. Nature Reviews Genetics, 2013, 14(2):80. [5] Jinek M, Chylinski K, Fonfara I, et al.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity[J]. Science, 2012, 337(6096):816-821. [6] Vigorito E, Kohlhaas S, Lu D, et al.miR-155:an ancient regulator of the immune system[J]. Immunol Rev, 2013, 253(1):146-157. [7] Rodriguez A, Vigorito E, Clare S, et al.Requirement of bic/microRNA-155 for normal immune function[J]. Science, 2007, 316(5824):608-611. [8] Vigorito E, Perks KL, Abreu-Goodger C, et al.microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells[J]. Immunity, 2007, 27(6):847-859. [9] Banerjee A, Schambach F, DeJong CS, et al. Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells[J]. European Journal of Immunology, 2010, 40(1):225-231. [10] O’Connell RM, Kahn D, Gibson WS, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development[J]. Immunity, 2010, 33(4):607-619. [11] Zhang J, Cheng Y, Cui W, et al.MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis[J]. Journal of Neuroimmunology, 2014, 266(1-2):56-63. [12] Zhang A, Wang K, Zhou C, et al.Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection[J]. J Heart Lung Transplant, 2017, 36(2):175-184. [13] Gracias DT, Stelekati E, Hope JL, et al.The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling[J]. Nature Immunology, 2013, 14(6):593-602. [14] O’Connell RM, Taganov KD, Boldin MP, et al. MicroRNA-155 is induced during the macrophage inflammatory response[J]. Proc Natl Acad Sci USA, 2007, 104(5):1604-1609. [15] Tili E, Michaille JJ, Cimino A, et al.Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock[J]. Journal of Immunology, 2007, 179(8):5082-5089. [16] Ceppi M, Pereira PM, Dunand-Sauthier I, et al.MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells[J]. Proc Natl Acad Sci USA, 2009, 106(8):2735-2740. [17] Ruggiero T, Trabucchi M, De Santa F, et al.LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages[J]. FASEB J, 2009, 23(9):2898-2908. [18] Tili E, Croce CM, Michaille JJ. miR-155:on the crosstalk between inflammation and cancer[J]. International Reviews of Immunology, 2009, 28(5):264-284. [19] Costinean S, Sandhu SK, Pedersen IM, et al.Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice[J]. Blood, 2009, 114(7):1374-1382. [20] Schulte LN, Westermann AJ, Vogel J.Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing[J]. Nucleic Acids Research, 2013, 41(1):542-553. [21] Li C, He H, Zhu M, et al.Molecular characterisation of porcine miR-155 and its regulatory roles in the TLR3/TLR4 pathways[J]. Developmental and Comparative Immunology, 2013, 39(1-2):110-116. [22] Cremer TJ, Ravneberg DH, Clay CD, et al:MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response[J]. PLoS One, 2009, 4(12):e8508. [23] Li X, Tian F, Wang F.Rheumatoid arthritis-associated microRNA-155 targets SOCS1 and upregulates TNF-alpha and IL-1beta in PBMCs[J]. International Journal of Molecular Sciences, 2013, 14(12):23910-23921. [24] Wang P, Hou J, Lin L, et al.Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1[J]. Journal of Immunology, 2010, 185(10):6226-6233. [25] Swaminathan G, Rossi F, Sierra LJ, et al.A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages[J]. PLoS Pathogens, 2012, 8(9):e1002937. [26] 陈洪波. 副猪嗜血杆菌感染:宿主免疫应答模型与巨噬细胞活化[J]. 畜牧兽医学报, 2015, 46(1):1-11. [27] 卓曲, 武力, 陈宝妮, 等. 蓝耳病病毒对猪肺泡巨噬细胞的影响[J]. 养猪, 2009(5):53-54. [28] Livak KJ, Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT Method[J]. Methods, 2001, 25(4):402-408. [29] Jing W, Zhang X, Sun W, et al.CRISPR/CAS9-mediated genome editing of miRNA-155 inhibits proinflammatory cytokine production by RAW264.7 cells[J]. BioMed Research International, 2015, 2015:326042-326042. [30] Zhou H, Huang X, Cui H, et al.miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells[J]. Blood, 2010, 116(26):5885-5894. [31] Shalem O, Sanjana NE, Hartenian E, et al.Genome-scale CRISPR-Cas9 knockout screening in human cells[J]. Science, 2014, 343(6166):84-87. |